Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 24, 2022
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionalsAndrea Poli, Alberico L Catapano, Alberto Corsini, et al.
Pharmacological Research|June 3, 2018
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paperAndrea Poli, Carlo M Barbagallo, Arrigo F G Cicero, et al.
EMBO Molecular Medicine|August 2, 2021
Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathyElena Sommariva, Ilaria Stadiotti, Michela Casella, et al.
European Heart Journal|February 20, 2015
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementErik S Stroes, Paul D Thompson, Alberto Corsini, et al.
Atherosclerosis. Supplements|May 21, 2014
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practiceNaveed A Sattar, Henry Ginsberg, Kausik Ray, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Giornale Italiano Di Cardiologia (2006)|March 14, 2018
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]Massimo Volpe, Giuliano Tocci, Domenico Accettura, et al.
Journal of the American College of Cardiology|December 12, 2024
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)Paola Gargiulo, Federica Marzano, Mario Crisci, et al.
Giornale Italiano Di Cardiologia (2006)|November 6, 2021
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]Allegra Battistoni, Giovanna Gallo, Caterina Oriana Aragona, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 24, 2022
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionalsAndrea Poli, Alberico L Catapano, Alberto Corsini, et al.
Pharmacological Research|June 3, 2018
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paperAndrea Poli, Carlo M Barbagallo, Arrigo F G Cicero, et al.
EMBO Molecular Medicine|August 2, 2021
Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathyElena Sommariva, Ilaria Stadiotti, Michela Casella, et al.
European Heart Journal|February 20, 2015
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementErik S Stroes, Paul D Thompson, Alberto Corsini, et al.
Atherosclerosis. Supplements|May 21, 2014
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practiceNaveed A Sattar, Henry Ginsberg, Kausik Ray, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Giornale Italiano Di Cardiologia (2006)|March 14, 2018
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]Massimo Volpe, Giuliano Tocci, Domenico Accettura, et al.
Journal of the American College of Cardiology|December 12, 2024
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)Paola Gargiulo, Federica Marzano, Mario Crisci, et al.
Giornale Italiano Di Cardiologia (2006)|November 6, 2021
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]Allegra Battistoni, Giovanna Gallo, Caterina Oriana Aragona, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 20